Risk factors for gout and prevention: A systematic review of the literature

Current Opinion in Rheumatology

Volumn 23, Issue 2, 2011, Pages 192-202

  Singh, Jasvinder A ^a,b,c,d   Reddy, Supriya G ^b,e   Kundukulam, Joseph ^b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF ALABAMA   (United States)

Author keywords

alcohol; chronic diseases; diet; gout; gouty arthritis; medications; risk factors; systematic review

Indexed keywords

ACETYLSALICYLIC ACID; COLCHICINE; FOLIC ACID; FRUCTOSE; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT; URICOSURIC AGENT;

ALCOHOL CONSUMPTION; CHRONIC DISEASE; COFFEE; COMORBIDITY; DIABETES MELLITUS; DIET; DISEASE EXACERBATION; EARLY MENOPAUSE; FOOD INTAKE; GOUT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; KIDNEY FAILURE; LIQUID; LOW DRUG DOSE; MEAT; MEDICAL LITERATURE; OBESITY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEA FOOD; SECONDARY PREVENTION; SYSTEMATIC REVIEW;

ALCOHOL DRINKING; DIETARY SUCROSE; GOUT; HUMANS; RISK FACTORS; SECONDARY PREVENTION;

EID: 79951577342     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283438e13     Document Type: Review

References (73)

1. Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford) 2007; 46:1441-1444. (Pubitemid 47317091)
2. Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 2008; 67:1310-1316.
3. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004; 31:1582-1587. (Pubitemid 39006641)
4. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20:895-900.
5. Abbott KC, Kimmel PL, Dharnidharka V, et al. New-onset gout after kidney transplantation: incidence, risk factors and implications. Transplantation 2005; 80:1383-1391. (Pubitemid 41803617)
6. Alvarez-Nemegyei J, Cen-Piste JC, Medina-Escobedo M, Villanueva-Jorge S. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout. J Rheumatol 2005; 32:1923-1927. (Pubitemid 41430484)
7. Anagnostopoulos I, Zinzaras E, Alexiou I, et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord 2010; 11:98.
8. Andracco R, Zampogna G, Parodi M, Cimmino MA. Risk factors for gouty dactylitis. Clin Exp Rheumatol 2009; 27:993-995.
9. Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008; 67:960-966. (Pubitemid 351956658)
10. Arromdee E, Michet CJ, Crowson CS, et al. Epidemiology of gout: is the incidence rising? J Rheumatol 2002; 29:2403-2406. (Pubitemid 35266034)
11. Bhole V, de Vera M, Rahman MM, et al. Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum 2010; 62:1069-1076.
12. Brauer GW, Prior IA. A prospective study of gout in New Zealand Maoris. Ann Rheum Dis 1978; 37:466-472. (Pubitemid 9074991)
13. Chang SJ, Ko YC, Wang TN, et al. High prevalence of gout and related risk factors in Taiwan's Aborigines. J Rheumatol 1997; 24:1364-1369. (Pubitemid 27353382)
14. Chen SY, Chen CL, Shen ML, Kamatani N. Trends in the manifestations of gout in Taiwan. Rheumatology (Oxford) 2003; 42:1529-1533. (Pubitemid 37521214)
15. Chen S-Y, Chen C-L, Shen M-L. Manifestations of metabolic syndrome associated with male gout in different age strata. Clin Rheumatol 2007; 26:1453-1457. (Pubitemid 47201683)
16. Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005; 165:742-748. (Pubitemid 40569426)
17. Choi HK, Atkinson K, Karlson EW, et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363:1277-1281. (Pubitemid 38496489)
18. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350:1093-1103. (Pubitemid 38298989)
19. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116:894-900. (Pubitemid 47300913)
20. Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum 2007; 57:816-821. (Pubitemid 46932088)
21. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008; 336:309-312. (Pubitemid 351278368)
22. Choi HK, DeVera MA, Krishnan E.Gout and the risk of type 2diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford) 2008; 47:1567-1570.
23. Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med 2009; 169:502-507.
24. Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum 2007; 56:2049-2055. (Pubitemid 47110404)
25. Choi JWJ, Ford ES, Gao X, Choi HK. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008; 59:109-116. (Pubitemid 351171885)
26. Chou CT, Lai JS. The epidemiology of hyperuricaemia and gout in Taiwan aborigines. Br J Rheumatol 1998; 37:258-262.
27. Cohen SD, Kimmel PL, Neff R, et al. Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol 2008; 19:2204-2210.
28. Creighton S, Miller R, Edwards S, et al. Is ritonavir boosting associated with gout? Int J STD AIDS 2005; 16:362-364. (Pubitemid 40704911)
29. Elliot AJ, Cross KW, Fleming DM. Seasonality and trends in the incidence and prevalenceofgout inEngland and Wales 1994-2007. Ann Rheum Dis 2009; 68:1728-1733.
30. Fam AG, Stein J, Rubenstein J. Gouty arthritis in nodal osteoarthritis. J Rheumatol 1996; 23:684-689. (Pubitemid 26132854)
31. Friedman JE, Dallal RM, Lord JL. Gouty attacks occur frequently in postoperative gastric bypass patients. Surgery 2008; 4:11-13.
32. Gurwitz JH, Kalish SC, Bohn RL, et al. Thiazide diuretics and the initiation of antigout therapy. J Clin Epidemiol 1997; 50:953-959. (Pubitemid 27423526)
33. Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women - the Third National Health and Nutrition Examination Survey. Arthritis Res Ther 2008; 10:R116.
34. Hak AE, Curhan GC, Grodstein F, Choi HK. Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis 2010; 69:1305-1309.
35. Hochberg MC, Thomas J, Thomas DJ, et al. Racial differences in the incidence of gout: the role of hypertension. Arthritis Rheum 1995; 38: 628-632.
36. Hunter DJ, York M, Chaisson CE, et al. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study [Erratum appears in J Rheumatol 2006; 33(8):1714]. J Rheumatol 2006; 33:1341-1345. (Pubitemid 44026423)
37. Janssens HJEM, van de Lisdonk EH, Janssen M, et al. Gout, not induced by diuretics? A case-control study from primary care. Ann Rheum Dis 2006; 65:1080-1083. (Pubitemid 44137165)
38. Kang EH, Lee EY, Lee YJ, et al. Clinical features and risk factors of post-surgical gout. Ann Rheum Dis 2008; 67:1271-1275.
39. Ko YC, Wang TN, Tsai LY, et al. High prevalence of hyperuricemia in adolescent Taiwan aborigines. J Rheumatol 2002; 29:837-842. (Pubitemid 34308460)
40. Lin KC, Lin HY, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 2000; 27:1501-1505. (Pubitemid 30354052)
41. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000; 27:1045-1050. (Pubitemid 30389766)
42. Li-Yu J, Clayburne G, Sieck M, et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001; 28:577-580. (Pubitemid 32202663)
43. Lyu L-C, Hsu C-Y, Yeh C-Y, et al. A case-control study of the association of diet and obesity with gout in Taiwan. Am J Clin Nutr 2003; 78:690-701. (Pubitemid 39663486)
44. Mijiyawa M, Oniankitan O. Risk factors for gout in Togolese patients. Joint Bone Spine 2000; 67:441-445.
45. Padang C, Muirden KD, Schumacher HR, et al. Characteristics of chronic gout in Northern Sulawesi, Indonesia. J Rheumatol 2006; 33:1813-1817. (Pubitemid 44373216)
46. Prior IA, Welby TJ, Ostbye T, et al. Migration and gout: the Tokelau Island migrant study. Br Med J (Clin Res Ed) 1987; 295:457-461. (Pubitemid 17127389)
47. Roubenoff R, Klag MJ, Mead LA, et al. Incidence and risk factors for gout in white men. JAMA 1991; 266:3004-3007.
48. Shibolet O, Elinav E, Ilan Y, et al. Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up study. Transplantation 2004; 77:1576-1580. (Pubitemid 38703041)
49. Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004; 51:321-325. (Pubitemid 38725128)
50. Shulten P, Thomas J, Miller M, et al. The role of diet in the management of gout: a comparison ofknowledge and attitudes to current evidence. J Hum Nutr Diet 2009; 22:3-11.
51. Stamp L, Ha L, Searle M, et al. Gout in renal transplant recipients. Nephrology 2006; 11:367-371. (Pubitemid 44086883)
52. Suppiah R, Dissanayake A, Dalbeth N. High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors. N Z Med J 2008; 121:43-50.
53. Tikly M, Bellingan A, Lincoln D, Russell A. Risk factors for gout: a hospital-based study in urban black South Africans. Rev Rhum Engl Ed 1998; 65:225-231. (Pubitemid 28198245)
54. Williams PT. Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr 2008; 87:1480-1487. (Pubitemid 351679793)
55. Wu EQ, Patel PA, Mody RR, et al. Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol 2009; 36:1032-1040.
56. Yu TF, Gutman AB. Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects. Ann Intern Med 1961; 55:179-192.
57. Zhang Y, Woods R, Chaisson CE, et al. Alcohol consumption as a trigger of recurrent gout attacks. Am J Med 2006; 119:800e13-800e18.
58. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks. Prescrire Int 2009; 18:63-65.
59. Al-Arfaj AS. Hyperuricemia in Saudi Arabia. Rheumatol Int 2001; 20:61-64. (Pubitemid 33779814)
60. Gutman AB, Yu TF. Prevention and treatment of chronic gouty arthritis. J Am Med Assoc 1955; 157:1096-1102.
61. Hanly JG, Skedgel C, Sketris I, et al. Gout in the elderly: a population health study. J Rheumatol 2009; 36:822-830.
62. Hutton I, Gamble G, Gow P, Dalbeth N. Factors associated with recurrent hospital admissions for gout: a case-control study. J Clin Rheumatol 2009; 15:271-274.
63. Johnson S. Effect of gradual accumulation of iron, molybdenum and sulfur, slow depletion of zinc and copper, ethanol or fructose ingestion and phlebotomy in gout. Med Hypotheses 1999; 53:407-412.
64. Klein R, Klein BEK, Tomany SC, Cruickshanks KJ. Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch Ophthalmol 2003; 121:674-678. (Pubitemid 36554470)
65. Kot TV, Day RO, Brooks PM. Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs? Med J Aust 1993; 159:182-184. (Pubitemid 23235826)
66. Kramer HJ, Choi HK, Atkinson K, et al. The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int 2003; 64:1022-1026. (Pubitemid 37013838)
67. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002; 40:37-42. (Pubitemid 34701209)
68. Talbott JH. Treating gout: successful methods of prevention and control. Postgrad Med 1978; 63:175-180. (Pubitemid 8354156)
69. Tsutsumi Z, Yamamoto T, Takahashi S, et al. Atherogenic risk factors in patients with gout. Adv Exp Med Biol 1998; 431:69-72. (Pubitemid 28236741)
70. Dalbeth N, Wong S, Gamble GD, et al. Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial. Ann Rheum Dis 2010; 69:1677-1682.
71. Dalbeth N, Gracey E, Pool B, et al. Identification of dairy fractions with anti-inflammatory properties in models of acute gout. Ann Rheum Dis 2010; 69:766-769.
72. Yu TF, Gutman AB. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest 1959; 38:1298-1315.
73. Caspi D, Lubart E, Graff E, et al. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000; 43:103-108. (Pubitemid 30368218)